Direktorat Registrasi ObatValid

GP D5 + ¼NS

BPOM Number: DKL2135310749A1
Approved: 5 July 2026
Expiry: 4 July 2031
Form: INFUS

About This Registration

GP D5 + ¼NS is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL2135310749A1. Its current registration status is Valid, with the licence valid until 4 July 2031. The product is registered to GRACIA PHARMINDO and manufactured by GRACIA PHARMINDO - INDONESIA. BPOM first approved this registration in July 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 6 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: SOFTBAG @ 500 ML (FLIP OFF PORT)
Department: Direktorat Registrasi Obat
Data Last Updated: 6 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

GRACIA PHARMINDO
Kota Bandung, Jawa Barat, Indonesia
NPWP: 020652582441000
owner
View profile →

Manufacturing Sites

GRACIA PHARMINDO - INDONESIA
KAB. SUMEDANG
primary
View profile →

Ingredients (5)

DEXTROSE MONOHYDRATE<DEXTROSE MONOHYDRATE&LTBR>BR&GTSODIUM CHLORIDE

Market Intelligence

Owner Portfolio: GRACIA PHARMINDO holds 160 BPOM registrations
Manufacturer Scale: GRACIA PHARMINDO - INDONESIA produces 156 registered products
Update Status: Recently updated (12 days ago)

FDA Cross-Reference

via openFDA

Generic Name: GUAIFENESIN AND PHENYLEPHRINE
Product Type: HUMAN OTC DRUG
Route of Administration: ORAL
Purpose: Active Ingredients (in each 5 mL teaspoonful) Purpose Guaifenesin 100 mg Expectorant Phenylephrine HCl 5 mg Nasal Decongestant

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.